MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$6,243K
Prepaid expenses and
other current assets
$382K
Total current assets
$6,625K
Operating lease
right-of-use asset
$992K
Other assets
$871K
Property and equipment,
net
$142K
Total assets
$8,630K
Accumulated deficit
-$482,612K
Total liabilities and
stockholders' deficit
$8,630K
Total stockholders'
deficit
-$16,752K
Additional paid-in capital
$465,850K
Class a common stock,
0.0001 par value...
$10K
Total liabilities
$25,382K
Warrant liabilities
$16,308K
Total current
liabilities
$6,669K
Convertible notes at fair
value, including...
$1,542K
Operating lease liability
$825K
Contingent consideration
liability
$38K
Other accrued
expenses
$2,183K
Accrued compensation
$1,832K
Accounts payable
$1,481K
Accrued clinical trials
expenses
$1,173K
Back
Back
Balance Sheet
AEON Biopharma, Inc. (AEON)
AEON Biopharma, Inc. (AEON)
source: myfinsight.com